Abstract Primary breast sarcomas are rare entities. These malignant tumors originate from mesenchymal glandular breast tissue and account for <1 % of all breast cancer cases. Angiosarcomas are rare malignant tumors that arise from endothelial cells lining vascular channels. Most angiosarcomas are secondary to radiotherapy treatments for breast cancer or to an arm lymphoedema subsequent to a modified radical mastectomy. Primary angiosarcomas are rare and account for 0.04 % of all malignant breast tumors.
A 22 year old female presented with 4 months history of awareness of painless progressive lump in left breast. There was no history of previous breast surgery or irradiation. On examination there was a large lump occupying all quadrants of left breast with skin nodules and plaques and pinkish blue discoloration (Fig. 1a) . Examination of axilla was unremarkable. Trucut biopsy from the lump was suggestive of vascular channels dissecting the stroma. Vascular channels were lined by plump endothelial cells with extensive haemorrhage and focal mitotic activity. Morphology suggested possibility of angiosarcoma. Immunohistochemistry (IHC) was positive for CD 31 and CD 34. Based on these findings provisional diagnosis of angiosarcoma of left breast was kept. Chest radiograph, ultrasonography of abdomen and F-18 bone scan were negative for metastatic disease. Patient underwent total mastectomy with level I axillary lymph node dissection with latissimus dorsi myocutaneous flap reconsruction. On gross examination tumour was well circumscribed measuring 17× 14×7 cm. Histopathologic examination (HPE) showed large gaping vascular channels lined by endothelial cells, focally arranged as lobular aggregates with atypical mitosis (5-6 per 10 high power fields) and focally congested vascular channels (Fig. 1b) . All margins were free of tumour. All 7 nodes resected were negative for malignancy. IHC was negative for cytokeratin and positive for CD 31 (Fig.1c) and CD 34. IHC was negative for estrogen and progesterone receptors. More than 75 % of bulk of tumour was formed by well differentiated pattern but there were significant foci showing solid areas with marked pleomorphism and mitotic activity. So, diagnosis of primary intermediate grade angiosarcoma of breast was made. Patient received 50 Gy radiation therapy to chest wall (2 Gy per fraction over 5 weeks) followed by three cycles of adriamycin and ifosfamide based chemotherapy. Following third cycle of chemotherapy she complained of bone pains. F-18 bone scan was done and it was suggestive of multiple bone metastasis while contrast enhanced computed tomogram of chest, abdomen and pelvis was negative for metastasis.
Discussion
Primary breast angiosarcoma is more frequent in young women (20 to 50 years) with no previous cancer history or other known risk factors [1, 2] . Between 6 and 12 % of primary breast angiosarcomas are diagnosed during pregnancy or shortly after, suggesting hormonal involvement. However, cases reported to display positive estrogen receptors are so rare, that it is presently impossible to establish a link between angiosarcomas and hormonal dependency [3, 4] . Patients with primary angiosarcoma present with a palpable mass that may be growing rapidly. Bluish skin discoloration occurs in up to a third of patients and is thought to be attributable to the vascular nature of the tumor. In the series by Yang et al. [5] , the mean tumor size of the mass at presentation was 5.9 cm, while in this case patient presented with a larger lump of size 17× 14×7 cm.
Radiologic characteristics may help to establish right diagnosis, but, most often, mammography is non specific and heterogeneous. Sonography and magnetic resonance imaging (MRI) are useful in characterizing breast lesions, but again there are no distinctive features of angiosarcomas [6, 7] .
Tumors smaller than 5 cm are usually associated with a better prognosis. With small tumors, recurrence is usually local and distant metastases are infrequent. However, tumors larger than 5 cm are associated with distant metastases, independent of local recurrence [8] .
There is a need for a close follow-up, including computed tomography scans at 6-month intervals. Liver is the most frequent metastatic site, followed by lung, lymph nodes, bones, bone marrow and, less frequently, ovary, kidney, omentum, adrenal gland, stomach, pancreas, peritoneum, esophagus, and skin.
Diagnosis prior to surgery, either by fine needle aspiration (FNA) or needle core biopsy (NCB), is difficult [3] . Chen et al. reported a percutaneous biopsy false-negative rate of 37 % [7] . Surgical resection and microscopic examination of sufficient sample of the tumour are often necessary to render a final diagnosis. Immunohistochemical examination (factor VIII and CD31 positivity) will confirm the vascular nature of the tumor [3, 7] . However in present case the diagnosis could be made pre-operatively on NCB with help of IHC. Differential diagnosis of this rare tumor include: benign hemangioma, cystosarcoma phyllodes, stromal sarcoma, metaplastic carcinoma, fibrosarcoma, liposarcoma, squamous cell carcinoma with sarcomatoid features, myoepithelioma, fibromatosis, and reactive spindle cell proliferative lesion [2, 8] . Surgical resection with mastectomy is the usual treatment. Since hematogenous dissemination is very common, axillary node dissection is not indicated [5, 8] . It is generally recognized that breast angiosarcomas have a bad prognosis. However, prognosis depends upon tumor grade (most important factor), tumor size at diagnosis, and margin status at surgery [5] . Pathologically, these tumors are subdivided into three groups according to the classification proposed by Donnel and et al. [9] . Grade I (well differentiated) contains open anastomosing vascular channels that proliferate within dermis, subcutaneous tissue or breast tissue. A single layer of endothelial cells lines these channels, which dissect through the stroma, causing distortion but little destruction of the preexisting lobules and ducts. Intermediate-grade angiosarcoma differs from low-grade by containing additional cellular foci of papillary formations and/or solid and spindle cell proliferation. The greater part of the tumor, however, is still composed of low-grade histology. Slightly increased mitotic activity is observed. In grade III endothelial tufting and papillary formations are prominent. Conspicuous solid and spindle cell areas, mostly devoid of vascular formations, are present as well. Mitoses may be brisk, especially in more cellular areas. Areas of hemorrhage, known as "blood lakes," and necrosis are also seen. The estimated probability of disease-free survival 5 years after initial treatment is 76 % for patients with grade 1 tumors; for patients with grade 3 tumors, the probability is 15 % [10] .
Chemotherapy and radiation therapy may be used as adjuvant treatment. However, the role of adjuvant chemotherapy is ill defined, because of the rarity of primary breast angiosarcoma and of the lack of prospective studies [5] . In most reported cases with use of chemotherapy, most authors prescribe cyclophosphamide, anthracycline, or an alkylating agent combined with a pyrimidine analogue. Since there is a high likelihood of locoregional recurrence, radiation therapy might be indicated even after a total mastectomy.
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